Israel Englander’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.3M | Sell |
40,500
-8,800
| -18% | -$4.22M | 0.01% | 1614 |
|
|
2026
Q1 | $24.2M | Sell |
49,300
-31,300
| -39% | -$17M | 0.01% | 1395 |
|
|
2025
Q4 | $46.7M | Buy |
80,600
+41,600
| +107% | +$23.5M | 0.02% | 873 |
|
|
2025
Q3 | $18.9M | Sell |
39,000
-13,900
| -26% | -$6.47M | 0.01% | 1718 |
|
|
2025
Q2 | $21.4M | Sell |
52,900
-19,400
| -27% | -$8.11M | 0.01% | 1510 |
|
|
2025
Q1 | $36M | Buy |
72,300
+700
| +1% | +$379K | 0.02% | 1003 |
|
|
2024
Q4 | $37.2M | Buy |
71,600
+22,800
| +47% | +$12.5M | 0.02% | 999 |
|
|
2024
Q3 | $30.2M | Sell |
48,800
-62,800
| -56% | -$37.2M | 0.01% | 1189 |
|
|
2024
Q2 | $61.7M | Buy |
111,600
+7,800
| +8% | +$4.47M | 0.03% | 674 |
|
|
2024
Q1 | $60.3M | Sell |
103,800
-61,500
| -37% | -$34.5M | 0.03% | 712 |
|
|
2023
Q4 | $87.7M | Buy |
165,300
+57,300
| +53% | +$27.7M | 0.04% | 483 |
|
|
2023
Q3 | $54.7M | Buy |
108,000
+19,700
| +22% | +$10.5M | 0.03% | 646 |
|
|
2023
Q2 | $46.1M | Buy |
88,300
+59,900
| +211% | +$32.3M | 0.02% | 790 |
|
|
2023
Q1 | $16.4M | Sell |
28,400
-121,900
| -81% | -$68.7M | 0.01% | 1514 |
|
|
2022
Q4 | $82.8M | Buy |
150,300
+122,800
| +447% | +$65.1M | 0.05% | 473 |
|
|
2022
Q3 | $13.9M | Buy |
27,500
+13,000
| +90% | +$7.28M | 0.01% | 1742 |
|
|
2022
Q2 | $7.88M | Buy |
14,500
+8,200
| +130% | +$4.51M | ﹤0.01% | 2313 |
|
|
2022
Q1 | $3.72M | Sell |
6,300
-30,900
| -83% | -$17.8M | ﹤0.01% | 3256 |
|
|
2021
Q4 | $24.8M | Sell |
37,200
-44,500
| -54% | -$27.8M | 0.01% | 1250 |
|
|
2021
Q3 | $46.7M | Buy |
81,700
+60,200
| +280% | +$33M | 0.03% | 673 |
|
|
2021
Q2 | $10.8M | Buy |
21,500
+4,500
| +26% | +$2.12M | 0.01% | 1804 |
|
|
2021
Q1 | $7.76M | Sell |
17,000
-12,300
| -42% | -$5.87M | 0.01% | 2072 |
|
|
2020
Q4 | $13.6M | Sell |
29,300
-16,400
| -36% | -$7.69M | 0.01% | 1393 |
|
|
2020
Q3 | $20.2K | Sell |
45,700
-2,700
| -6% | -$1.12M | 0.02% | 797 |
|
|
2020
Q2 | $17.5M | Buy |
48,400
+38,400
| +384% | +$12.9M | 0.02% | 815 |
|
|
2020
Q1 | $2.84M | Buy |
+10,000
| New | +$3.15M | 0.01% | 1769 |
|
|
2019
Q4 | – | Sell |
-2,600
| Closed | -$757K | – | 4634 |
|
|
2019
Q3 | $757K | Buy |
+2,600
| New | +$745K | ﹤0.01% | 3022 |
|
|
2019
Q1 | – | Sell |
-5,000
| Closed | -$1.12M | – | 4329 |
|
|
2018
Q4 | $1.12M | Buy |
+5,000
| New | +$1.17M | ﹤0.01% | 2524 |
|
|
2014
Q2 | – | Sell |
-30,000
| Closed | -$3.61M | – | 3877 |
|
|
2014
Q1 | $3.61M | Buy |
+30,000
| New | +$3.57M | 0.01% | 1404 |
|
Other funds holding TMO
Israel Englander's TMO Position: Q2 2026 in Review
Israel Englander increased its Thermo Fisher Scientific (TMO) stake by 134% in Q2 2026, buying an estimated $45.5M and bringing the position to 165,475 shares worth $83M. The position accounts for 0.03% of the portfolio, ranked #604.
Israel Englander first reported a position in TMO in Q2 2013 and has held it in 51 quarters since. The position peaked at $313M in Q2 2024. 2,606 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Israel Englander held 165,475 shares of Thermo Fisher Scientific worth $83M as of Q2 2026.
- Israel Englander bought 94,779 Thermo Fisher Scientific shares in Q2 2026, an estimated $45.5M.
- Thermo Fisher Scientific made up 0.03% of Israel Englander's portfolio in Q2 2026, its #604 holding.
- Israel Englander first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 51 quarters since.
- Israel Englander's Thermo Fisher Scientific position peaked at $313M in Q2 2024.
- 2,606 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.